Search

Your search keyword '"Strecker, Thomas"' showing total 445 results

Search Constraints

Start Over You searched for: Author "Strecker, Thomas" Remove constraint Author: "Strecker, Thomas"
445 results on '"Strecker, Thomas"'

Search Results

3. Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies

5. Hexestrol, an estrogen receptor agonist, inhibits Lassa virus entry

6. Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection

8. Rvsv-Zebov Vaccination in People with Pre-Existing Immunity to Ebolavirus: An Open-Label Safety and Immunogenicity Study in Guinean Communities Affected by Ebola Virus Disease (L’Essai Proches)

9. Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study

10. Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responses

12. Ebola Virus Neutralizing Antibodies in Dogs from Sierra Leone, 2017

16. Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity

17. Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever

21. Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015

29. Unique human immune signature of Ebola virus disease in Guinea

30. Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis

31. Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa

33. Lassa virus glycoprotein nanoparticles elicit a neutralizing antibody that defines a new site of vulnerability

36. Effects of Donor Pre-Treatment With Dopamine on Survival After Heart Transplantation: A Cohort Study of Heart Transplant Recipients Nested in a Randomized Controlled Multicenter Trial

37. Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

38. A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

39. Effect of Artesunate–Amodiaquine on Mortality Related to Ebola Virus Disease

40. CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor

41. Safety and immunogenicity of rVSV[DELTA]G-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial

42. Polymer microarrays rapidly identify competitive adsorbents of virus-like particles

45. Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity

46. Polymer microarrays rapidly identify competitive adsorbents of virus-like particles (VLPs)

Catalog

Books, media, physical & digital resources